Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 21.4915.4015.663.982.20

What is the latest EV/Core EBITDA ratio of PIRAMAL PHARMA ?

The latest EV/Core EBITDA ratio of PIRAMAL PHARMA is 21.49 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.49
Mar202415.40
Mar202315.66
Mar20223.98
Mar20212.20

How is EV/Core EBITDA of PIRAMAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 21.49
39.55
Mar2024 15.4
-1.66
Mar2023 15.66
293.47
Mar2022 3.98
80.91
Mar2021 2.2 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/Core EBITDA ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,357.1 Cr -2.2% -12.4% -32.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,705.0 Cr -0.7% 2% -1.7% Stock Analytics
DIVIS LABORATORIES ₹167,091.0 Cr -2.1% -2.8% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,555.0 Cr -0.9% -0.6% 12.2% Stock Analytics
CIPLA ₹120,919.0 Cr -1% -1.2% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,165.0 Cr -0.1% 2.3% 2.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-2.2%

-12.4%

-32.4%

SENSEX

0.2%

-0.5%

4%


You may also like the below Video Courses